PharmaBoardroom

Asli Özelli – Executive Director, AmCham Turkey

AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with over USD 50 billion in investment,…

Life Science VC Funding in Japan: Signs of Growth & Untapped…

Toshio Fujimoto, MD, MBA, the General Manager of Shonan Health Innovation Park examines why Japan – despite being well established as one of the…

Switzerland Biotech Listing Snapshot 2021

The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI) by 38 percent and NASDAQ Biotech by 46 per cent between 2015 and 2020.…

Ümit Dereli – Secretary General, AIFD, Turkey

Ümit Dereli is secretary general of the Turkish Association of Research-Based Pharmaceutical Companies (AIFD), which has 35 multinational member…

MSD Switzerland AVP on Recent Zurich R&D Investment

In February 2020, US giant MSD announced the launch of a new site in Zurich specialising in R&D, data management, and commercialisation,…

China Pharma News: Antitrust Threat to Pharma; June BioNTech…

The latest China pharma news, including the upcoming first domestic approval for a foreign COVID-19 vaccine in June; the potential of Western China as…

UK Pharma News: Fastest Growing Private Pharmacos; GSK Shake-Up;…

The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma giant; CDMO Sterling’s latest…

Michael Altorfer – CEO, Swiss Biotech Association

Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the Swiss biotech industry, discusses…